A. Alex

Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal

R. Riechelmann, P. Hoff, C. Moniz, 2016, Journal of Gastrointestinal Cancer.

The effects of palliative chemotherapy in metastatic colorectal cancer patients with an ECOG performance status of 3 and 4.

R. Riechelmann, P. Hoff, J. Sabbaga, 2015, Clinical colorectal cancer.

Response to Chemotherapy and Prognosis in Metastatic Colorectal Cancer With DNA Deficient Mismatch Repair

R. Riechelmann, P. Hoff, S. Siqueira, 2017, Clinical colorectal cancer.

Phase 2 Trial of Metformin Combined With 5-Fluorouracil in Patients With Refractory Metastatic Colorectal Cancer.

R. Riechelmann, P. Hoff, M. Braghiroli, 2016, Clinical colorectal cancer.

Phase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreas

R. Riechelmann, P. Hoff, M. Braghiroli, 2015, Ecancermedicalscience.

Non-inferiority cancer clinical trials: scope and purposes underlying their design.

R. Riechelmann, P. Hoff, G. Bariani, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreas.

R. Riechelmann, P. Hoff, M. Braghiroli, 2014 .